sofosbuvir has been researched along with Anemia, Sickle Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brainard, DM; Hyland, RH; Lanzkron, S; McHutchison, JG; Moon, J; Sulkowski, M; Zhang, F | 1 |
Fischler, B; Priftakis, P; Sundin, M | 1 |
Check Hayden, E | 1 |
3 other study(ies) available for sofosbuvir and Anemia, Sickle Cell
Article | Year |
---|---|
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease.
Topics: Adult; Anemia, Sickle Cell; Antiviral Agents; Benzimidazoles; Drug Combinations; Female; Fluorenes; Hepatitis C, Chronic; Humans; Male; Middle Aged; Sofosbuvir; Young Adult | 2017 |
Sofosbuvir and Simeprevir Treatment of a Stem Cell Transplanted Teenager With Chronic Hepatitis C Infection.
Topics: Adolescent; Anemia, Sickle Cell; Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; Edema; Hepatitis C, Chronic; Humans; Male; Protease Inhibitors; Simeprevir; Sofosbuvir; Stem Cell Transplantation; Sustained Virologic Response; Transplant Recipients | 2016 |
Promising gene therapies pose million-dollar conundrum.
Topics: Aminophenols; Anemia, Sickle Cell; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biotechnology; Cystic Fibrosis; Drug Costs; Drug Industry; Genetic Therapy; Humans; Insurance, Health; Neoplasms; Quinolones; Sofosbuvir | 2016 |